Barry E Greene insider trades

Open-market stock purchases and sales by Barry E Greene, Director at City Therapeutics, Inc, from SEC Form 4 filings since Jun 9, 2010.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -84%.

Recent trades

DateStockTradeValue
Oct 15, 2026CTY City Therapeutics, IncBought (not open market)—
Jun 22, 2026DYN Dyne Therapeutics, IncBought (not open market)—
May 21, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—

Companies traded

  • CTY City Therapeutics, Inc: other filings, last Oct 15, 2026
  • DYN Dyne Therapeutics, Inc: other filings, last Jun 22, 2026
  • KPTI Karyopharm Therapeutics Inc: 1 buy, last May 21, 2026
  • SAGE Sage Therapeutics, Inc: 3 buys, last Jul 31, 2025
  • ACOR Acorda Therapeutics Inc: 3 sales, last Jun 2, 2021
  • ALNY Alnylam Pharmaceuticals, Inc: 5 buys, 28 sales, last Sep 9, 2020
  • RGLS Regulus Therapeutics Inc: other filings, last Nov 5, 2012

Get free alerts when Barry E Greene files a new trade →